Matt Hubert
About Matt Hubert
Matt Hubert is a Business Director at Magnolia Medical Technologies, with a diverse background in sales and clinical roles across various companies. He has over 15 years of experience in the medical and sales industries, including significant contributions to the clinical adoption of innovative medical technologies.
Current Role at Magnolia Medical Technologies
Matt Hubert serves as the Business Director at Magnolia Medical Technologies since 2019. In this role, he focuses on driving the clinical adoption of Steripath, a product aimed at reducing false-positive sepsis results. His efforts are directed towards leading academic institutions, government military and VA medical centers, as well as community hospitals across the country.
Previous Experience in Sales and Management
Matt Hubert has extensive experience in sales and management across various organizations. He worked as a Sales Representative at VWR from 2003 to 2005 and later served as a Regional Sales Manager at T2 Biosystems from 2015 to 2017. His roles at Nanosphere included Senior Clinical Sales Specialist from 2014 to 2015 and Clinical Sales Specialist from 2011 to 2013. He also held positions at mtm laboratories, Inc. as Senior Account Executive and at Siemens Healthineers as Molecular Sales Specialist.
Military Background
Matt Hubert served in the US Air Force Reserve as a Staff Sergeant from 1989 to 1994. His service took place at Bergstrom AFB in Austin, TX, where he gained valuable skills and experience that contributed to his professional development.
Educational Background
Matt Hubert studied at Texas State University, where he earned a Bachelor’s Degree in Fine Arts, Theatre from 1988 to 1993. This educational background provided him with a foundation that complements his professional pursuits in the business and medical sectors.
Intellectual Property Contributions
Matt Hubert is involved in a company that possesses an intellectual property portfolio featuring more than 70 issued patents, along with over 50 additional patent applications pending. This involvement highlights his engagement in innovative practices within the medical technology field.